Seeing Is Believing
AMGN is currently covered by 24 analysts with an average price target of $321.52. This is a potential upside of $34.42 (11.99%) from yesterday's end of day stock price of $287.1.
Amgen's activity chart (see below) currently has 524 price targets and 474 ratings on display. The stock rating distribution of AMGN is 52.81% BUY, 8.99% SELL and 38.2% HOLD.
Analysts average stock forecasts to be materialized ratio is 87.65% with an average time for these price targets to be met of 571.88 days.
Highest price target for AMGN is $380, Lowest price target is $215, average price target is $311.15.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 16-May-2025.
Amgen is a biotechnology company that specializes in developing, manufacturing, and delivering human therapeutics.
The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.
Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.
Currently out of the existing stock ratings of AMGN, 47 are a BUY (52.81%), 8 are a SELL (8.99%), 34 are a HOLD (38.2%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$328
$39.82 (13.82%)
$329
20 days ago
(16-May-2025)
1/3 (33.33%)
$55.59 (20.41%)
54
Hold
$280
$-8.18 (-2.84%)
$235
29 days ago
(07-May-2025)
17/21 (80.95%)
$4.16 (1.51%)
406
Buy
$320
$31.82 (11.04%)
$324
1 months 3 days ago
(02-May-2025)
12/16 (75%)
$38.78 (13.79%)
75
Hold
$330
$41.82 (14.51%)
$303
1 months 27 days ago
(09-Apr-2025)
13/14 (92.86%)
$38.91 (13.37%)
730
Sell
$294
$5.82 (2.02%)
$275
3 months ago
(05-Mar-2025)
4/5 (80%)
$-18.19 (-5.83%)
89
What is AMGN (Amgen) average time for price targets to be met?
Which analyst has the current highest performing score on AMGN (Amgen) with a proven track record?
Which analyst has the most public recommendations on AMGN (Amgen)?
Which analyst is the currently most bullish on AMGN (Amgen)?
Which analyst is the currently most reserved on AMGN (Amgen)?